THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kenichi Tanaka to Cardiopulmonary Bypass

This is a "connection" page, showing publications Kenichi Tanaka has written about Cardiopulmonary Bypass.
Connection Strength

4.934
  1. Hematologic evaluation of intraoperative autologous blood collection and allogeneic transfusion in cardiac surgery. Transfusion. 2021 03; 61(3):788-798.
    View in: PubMed
    Score: 0.719
  2. Toward Optimal Anticoagulation Monitoring During Cardiopulmonary Bypass: It Is Still A Tough "ACT". J Cardiothorac Vasc Anesth. 2020 11; 34(11):2928-2930.
    View in: PubMed
    Score: 0.694
  3. Perioperative Management of Patients With Hereditary Angioedema With Special Considerations for Cardiopulmonary Bypass. Anesth Analg. 2020 07; 131(1):155-169.
    View in: PubMed
    Score: 0.693
  4. Acute Intracardiac Thrombosis and Pulmonary Thromboembolism After Cardiopulmonary Bypass: A Systematic Review of Reported Cas. Anesth Analg. 2018 Feb; 126(2):425-434.
    View in: PubMed
    Score: 0.586
  5. Perioperative Coagulation Management of a Hemophilia A Patient During Cardiac Surgery. Semin Cardiothorac Vasc Anesth. 2017 Dec; 21(4):312-320.
    View in: PubMed
    Score: 0.554
  6. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg. 2008 Mar; 106(3):713-8, table of contents.
    View in: PubMed
    Score: 0.295
  7. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. Anesth Analg. 2007 Apr; 104(4):763-5.
    View in: PubMed
    Score: 0.277
  8. A Pharmacokinetic and Plasmin-Generation Pharmacodynamic Assessment of a Tranexamic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2022 08; 36(8 Pt A):2473-2482.
    View in: PubMed
    Score: 0.192
  9. A Pharmacokinetic and Pharmacodynamic Investigation of an e-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2021 Feb; 35(2):406-417.
    View in: PubMed
    Score: 0.174
  10. Heparin-Induced Thrombocytopenia and Cardiac Surgery: Can We Do It All With Cangrelor? A A Pract. 2019 11 01; 13(9):366.
    View in: PubMed
    Score: 0.165
  11. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery. J Cardiothorac Vasc Anesth. 2018 08; 32(4):1609-1614.
    View in: PubMed
    Score: 0.146
  12. Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass. Anesth Analg. 2016 Apr; 122(4):935-42.
    View in: PubMed
    Score: 0.129
  13. Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery. J Anesth. 2016 06; 30(3):369-76.
    View in: PubMed
    Score: 0.127
  14. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):959-63.
    View in: PubMed
    Score: 0.086
  15. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg. 2008 Mar; 106(3):732-8, table of contents.
    View in: PubMed
    Score: 0.074
  16. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients. Anesth Analg. 2012 Aug; 115(2):244-52.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES